Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New bioimaging collaboration to bolster infectious disease research
The collaboration will greatly improve the UK's national capabilities

Electron microscopes will allow more detailed study of viral diseases

The Pirbright Institute and Diamond Light Source have announced a new-five year collaboration that will allow both institutions to make advancements in their research. This agreement will improve research and innovation identified by the UK Research and Innovation (UKRI) infrastructure programme.

Pirbright’s head of bioimaging Professor Pippa Hawes will be working at both sites, helping to prepare Pirbright research projects for high resolution electron microscopy and contributing to Diamond’s development initiatives.

Commenting on the agreement, Prof Hawes says: “There is a lot of preparatory work that can be carried out at Pirbright with our microscopes. We can use them to really define the questions we need to answer and then ensure we have samples prepared in a way that will maximise their use at Diamond.”

Diamond, the UK’s national synchrotron, has an embedded cryo-electron microscope facility, known as Electron Bio-Imaging Centre (eBIC). These powerful microscopes are capable of solving protein molecular structures to below 0.3 nm resolution, and are well suited to projects that involve understanding the cell biology of virus-host interactions, as well as how viruses replicate.

The microscopes have also enabled the design of a new vaccine for the foot-and-mouth disease virus (FMDV), through allowing Pirbright scientists to view the outer shell of the vaccine. This vaccine has recently been licensed for further development.

Director of Pirbright, Bryan Charleston comments: “A long and productive association between Pirbright and Diamond exists that has resulted in vital research developments such as the visualisation of the FMDV capsid, bluetongue virus and bovine antibody structures. We hope this agreement will aid our ambition to understand the biology of high consequence viruses and expand the range of programmes exploring solutions to control current and emerging problems.”

Become a member or log in to add this story to your CPD history

Voting opens for BEVA Council

News Story 1
 Eligible members of BEVA will be able to vote for their Council team until Monday, 17 August 2026. Members will have received an election email on 17 July.

There are five candidates standing for four available places on Council. They are:

  • Alexandre Triguino
  • Angela Jones
  • Beth Bryant
  • Holly Rees
  • Hugh Somerville
Full profiles for each candidate can be found on the BEVA website

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'